碳水化合物反应元件结合蛋白/缺氧诱导因子-1α信号通路在脓毒症相关性脑病大鼠中的作用
研究用腹腔注射LPS 10 mg/kg诱导大鼠脓毒症相关性脑病(SAE)模型,实验1确定48小时为造模条件,此时海马ChREBP、HIF-1α表达升高,IL-6、TNF-α、IL-10及乳酸/丙酮酸比值升高,认知功能下降。实验2显示CR1(15 mg/kg,每24小时腹腔注射)可改善SAE大鼠认知功能、减轻神经炎症、微胶质细胞M1极化、血脑屏障通透性及神经元损伤,并下调ChREBP、HIF-1α及cleaved caspase-3表达;联合高浓度葡萄糖(1 g/kg,每6小时)可逆转CR1的上述效应。结论提示ChREBP/HIF-1α通路参与SAE进展,CR1可能通过抑制该通路减轻SAE。
要点
- 大鼠腹腔注射LPS 10 mg/kg 48小时可诱导SAE模型,表现为认知功能下降、海马ChREBP与HIF-1α表达升高及神经炎症。
- SAE大鼠海马IL-6、TNF-α、IL-10及乳酸/丙酮酸比值升高,Evans蓝升高提示血脑屏障通透性增加,血清NSE、S100β升高。
- CR1 15 mg/kg每24小时腹腔注射可提高SAE大鼠冻结时间比[(15.1±2.2)% vs. (6.9±1.6)%]和辨别指数[(53.0±5.6)% vs. (41.0±6.0)%]。
- CR1降低海马Evans蓝、IL-6、TNF-α及乳酸/丙酮酸比值,降低血清NSE、S100β,并下调ChREBP、HIF-1α、cleaved caspase-3表达。
- 高浓度葡萄糖(1 g/kg每6小时)可逆转CR1对SAE大鼠的上述保护效应。
适用人群与场景
- 健康雄性Sprague-Dawley大鼠,实验1共42只,实验2共48只。
- 实验1设对照组(n=6)、24小时LPS组(n=12)、48小时LPS组(n=12)、72小时LPS组(n=12)。
- 实验2设对照组(n=12)、SAE组(n=12)、SAE+CR1组(n=12)、SAE+CR1+高糖组(n=12)。
诊断标准与关键阈值
- SAE造模条件:腹腔注射LPS 10 mg/kg,持续48小时,依据为48小时起出现认知功能下降及海马病理改变。
处置流程与药物剂量
- 实验1:对照组腹腔注射等体积生理盐水;LPS组腹腔注射LPS 10 mg/kg,分别持续24、48、72小时。
- 实验2:对照组注射等剂量溶剂;SAE组腹腔注射LPS 10 mg/kg诱导SAE;SAE+CR1组在SAE诱导后腹腔注射CR1 15 mg/kg,每24小时一次;SAE+CR1+高糖组在SAE诱导后腹腔注射CR1 15 mg/kg每24小时一次,联合高浓度葡萄糖1 g/kg每6小时一次。
研究设计与关键结果
- 实验1:与对照组相比,LPS暴露48小时起,大鼠冻结时间比和辨别指数降低,海马ChREBP、HIF-1α表达升高,IL-6、TNF-α、IL-10水平及乳酸/丙酮酸比值升高,退变神经元数量增加、神经元数量减少(均P<0.05),伴神经元排列紊乱、尼氏体减少、核固缩和深染增加。
- 实验2:与对照组相比,SAE组大鼠冻结时间比和辨别指数降低,海马Evans蓝、IL-6、TNF-α、IL-10水平及乳酸/丙酮酸比值升高,外周血NSE和S100β升高,神经元退变增加、神经元密度降低,海马微胶质细胞明显激活及M1极化,ChREBP、HIF-1α、cleaved caspase-3蛋白表达上调(均P<0.05)。
- 与SAE组相比,CR1治疗组冻结时间比[(15.1±2.2)% vs. (6.9±1.6)%]和辨别指数[(53.0±5.6)% vs. (41.0±6.0)%]升高(均P<0.05)。
- 与SAE组相比,CR1治疗组海马Evans蓝[(2.09±0.26) mg/g vs. (2.94±0.42) mg/g]、IL-6[(96.56±11.50) ng/g vs. (176.50±21.20) ng/g]、TNF-α[(176.50±21.20) ng/g vs. (298.66±34.60) ng/g]及乳酸/丙酮酸比值[(14.76±3.65) vs. (25.62±3.44)]降低(均P<0.05)。
- 与SAE组相比,CR1治疗组血清NSE[(20.37±2.65) ng/L vs. (31.22±4.13) ng/L]和S100β[(100.83±11.25) ng/L vs. (165.55±21.26) ng/L]降低(均P<0.05),微胶质细胞激活和M1极化程度减轻,神经元退变减轻、神经元密度增加,ChREBP、HIF-1α、cleaved caspase-3蛋白表达下调(均P<0.05)。
- 高糖干预可逆转CR1的上述效应。
证据类型、等级与局限
- 证据类型:大鼠实验研究(动物实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ChREBP特异性拮抗剂通过抑制ChREBP/HIF-1α通路减轻促炎性微胶质细胞极化和神经炎症,从而减轻SAE海马组织病理损伤和认知功能障碍。
- 作者认为,LPS暴露上调ChREBP和HIF-1α表达并促进神经炎症和认知功能障碍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the role of the carbohydrate response element-binding protein/hypoxia-inducible factor-1α (ChREBP/HIF-1α) signaling pathway in sepsis-associated encephalopathy (SAE) in rats.
METHODS: 1) Experiment 1: Forty-two healthy male Sprague-Dawley rats were randomly assigned to a control group (n=6), a 24-hour LPS group (n=12), a 48-hour LPS group (n=12), and a 72-hour LPS group (n=12). The control group was injected with an equal volume of normal saline. Rats in the LPS groups were treated with intraperitoneal lipopolysaccharide (LPS, 10 mg/kg) for 24, 48, or 72 hours to induce SAE. Cognitive function was evaluated by behavioral tests. Histopathological changes in the hippocampus were observed under light microscopy. Levels of pro-inflammatory mediators and glycolytic metabolites in the hippocampus were determined by enzyme-linked immunosorbent assay (ELISA). Hippocampal protein expressions of ChREBP and HIF-1α were measured by Western blotting to assess their association with SAE progression. 2) Experiment 2: Forty-eight healthy male Sprague-Dawley rats were randomly assigned to a control group (n=12), an LPS-induced SAE group (SAE group, n=12), an SAE+ChREBP-specific antagonist ChREBPα/14-3-3 regulator-1 (CR1) group (n=12), and an SAE+CR1+high-glucose (Glu) group (n=12). The control group was injected with an equal dose of vehicle. SAE was induced in the SAE group by intraperitoneal injection of LPS (10 mg/kg). In the SAE+CR1 group, CR1 (15 mg/kg) was intraperitoneally administered once every 24 hours after SAE induction. In the SAE+CR1+Glu group, CR1 (15 mg/kg) was administered once every 24 hours after SAE induction in combination with high-concentration Glu (1 g/kg, once every 6 hours). Cognitive function was assessed by behavioral tests. Histopathological changes in the hippocampus were observed under light microscopy. The changes of microglia in the hippocampus were observed under a fluorescence microscope. Blood-brain barrier permeability, inflammatory mediator, glycolytic metabolism, and neuronal injury markers levels were measured by ELISA. Expressions of glycolytic enzymes and apoptosis-related proteins in the hippocampus were determined by Western blotting to evaluate the relationship between SAE and the ChREBP/HIF-1α signaling pathway.
RESULTS: 1) Results of experiment 1: Compared with the control group, from LPS exposure for 48 hours on, the freezing time ratio and discrimination index reduced, the expressions of ChREBP and HIF-1α increased, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), IL-10 levels and lactic acid/pyruvate ratio (LPR) elevated, and the number of degenerative neurons increased and neuronal number decreased (all P<0.05). These changes were accompanied by disordered neuronal arrangement, reduced Nissl bodies, and increased nuclear pyknosis and hyperchromasia. Therefore, intraperitoneal injection of 10 mg/kg LPS for 48 hours was selected as the condition for SAE model establishment in subsequent experiments. 2) Results of experiment 2: Compared with the control group, rats in the SAE group exhibited significant cognitive impairment and neuroinflammation, as evidenced by decreased freezing time ratio and discrimination index, increased hippocampal Evans blue, IL-6, TNF-α, IL-10 levels and LPR, elevated peripheral blood levels of neuron specific enolase (NSE) and S100β, increased neuronal degeneration and reduced neuronal density, and the obvious microglial activation and M1 polarization in the hippocampus, as well as the upregulated protein expressions of ChREBP, HIF-1α, and cleaved caspase-3 (all P<0.05). Compared with the SAE group, CR1 treatment significantly improved the cognitive function, metabolism, inflammation, cell polarization, and apoptosis in rats. The freezing time ratio and the discrimination index were increased [freezing time ratio: (15.1±2.2)% vs. (6.9±1.6)%, discrimination index: (53.0±5.6)% vs. (41.0±6.0)%, both P<0.05]. The hippocampal Evans blue, IL-6, TNF-α levels and LPR were reduced [Evans blue (mg/g): 2.09±0.26 vs. 2.94±0.42, IL-6 (ng/g): 96.56±11.50 vs. 176.50±21.20, TNF-α (ng/g): 176.50±21.20 vs. 298.66±34.60, LPR: 14.76±3.65 vs. 25.62±3.44, all P<0.05]. The activation of microglia and the degree of M1 polarization were reduced. Serum NSE and S100β levels were also reduced [NSE (ng/L): 20.37±2.65 vs. 31.22±4.13, S100β (ng/L): 100.83±11.25 vs. 165.55±21.26, both P<0.05]. Neuronal degeneration was alleviated and neuronal density increased. The protein expressions of ChREBP, HIF-1α, and cleaved caspase-3 were all downregulated (all P<0.05). However, these effects of CR1 were reversed by high-Glu intervention.
CONCLUSIONS: LPS exposure upregulates the expressions of ChREBP and HIF-1α and promotes neuroinflammation and cognitive dysfunction. A ChREBP-specific antagonist attenuates pro-inflammatory microglial polarization and neuroinflammation by inhibiting the ChREBP/HIF-1α pathway, thereby alleviating hippocampal histopathological injury and cognitive dysfunction in SAE.
参考来源
- Ni C, Ding Y, Jiang Z, et al. [Role of carbohydrate response element-binding protein/hypoxia-inducible factor-1α signaling pathway in sepsis-associated encephalopathy in rats]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42200246. doi:10.3760/cma.j.cn121430-20250505-00248
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。